亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Efficacy of Selective Vidian Neurectomy for Allergic Rhinitis Combined with Chronic Rhinosinusitis

医学 神经切除术 可视模拟标度 鼻息肉 鼻漏 外科 慢性鼻-鼻窦炎 功能性内窥镜鼻窦手术 鼻窦炎 内科学 替代医学 病理
作者
Yan Qi,Junqi Liu,Shu-Ya Peng,Siyuan Hou,Mingxia Zhang,Zhenlin Wang
出处
期刊:ORL [Karger Publishers]
卷期号:83 (5): 327-334 被引量:14
标识
DOI:10.1159/000512083
摘要

The aim of this study was to investigate the efficacy of endoscopic selective vidian neurectomy in the treatment of severe persistent allergic rhinitis (AR) combined with chronic rhinosinusitis (CRS) with nasal polyps (ARwCRSwNP).One hundred thirty patients with moderate to severe persistent ARwCRSwNP were enrolled at Xuanwu Hospital, Capital Medical University, from September 2015 to September 2017. Patients were divided into 2 groups. Sixty-one patients (the control group) underwent conventional surgical treatment for CRS with nasal polyps and received conservative treatment for AR. Sixty-nine patients (the experimental group) received conventional surgical treatment for CRS with nasal polyps plus endoscopic selective vidian neurectomy with amputation of the posterior nasal nerve and pharyngeal branch of the vidian nerve. Clinical parameters, including visual analog scale (VAS) score, Lund-Kennedy endoscopic mucosal morphology score, and Lund-Mackay sinus computed tomography (CT) scan lesion range score, were used to analyze and evaluate the preoperative and postoperative data. Comparisons were based on patient scores, and preoperative and postoperative scores obtained at 6, 12, and 24 months were analyzed.The experimental group had higher therapeutic efficacy in nasal obstruction, nasal itching, rhinorrhea, sneezing, and general symptoms than the control group (p < 0.05). No complications such as tear-secretion disorder or atrophic rhinitis occurred in the experimental group, and no significant difference in complications incidence was observed between the 2 groups (p > 0.05).Endoscopic selective vidian neurectomy is an effective and safe technique for the management of moderate to severe persistent ARwCRSwNP.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
6秒前
Shawn发布了新的文献求助10
6秒前
科研通AI6.2应助yoozii采纳,获得10
14秒前
星辰大海应助Shawn采纳,获得10
14秒前
默默的以柳完成签到,获得积分10
35秒前
43秒前
默默无闻完成签到 ,获得积分10
46秒前
48秒前
阿洁发布了新的文献求助10
55秒前
Orange应助Nature采纳,获得10
1分钟前
闪闪访波完成签到,获得积分10
1分钟前
silence完成签到,获得积分10
1分钟前
英勇的落雁完成签到,获得积分10
1分钟前
完美世界应助科研通管家采纳,获得10
2分钟前
彭于晏应助科研通管家采纳,获得10
2分钟前
美丽的沛菡完成签到,获得积分10
3分钟前
sadh2完成签到 ,获得积分10
3分钟前
Kao应助霸气侧漏采纳,获得10
3分钟前
3分钟前
yoozii发布了新的文献求助10
3分钟前
郭濹涵完成签到 ,获得积分10
3分钟前
楚科研完成签到 ,获得积分10
3分钟前
心随以动完成签到 ,获得积分10
3分钟前
3分钟前
秀秀发布了新的文献求助10
3分钟前
3分钟前
修辛完成签到 ,获得积分10
4分钟前
4分钟前
真实的荣轩完成签到,获得积分10
4分钟前
Nature发布了新的文献求助10
4分钟前
科研通AI6.2应助秀秀采纳,获得10
4分钟前
Akim应助pete采纳,获得10
4分钟前
QQQ完成签到,获得积分10
4分钟前
酷酷的雨完成签到,获得积分10
5分钟前
5分钟前
5分钟前
领导范儿应助健康的忆寒采纳,获得10
6分钟前
6分钟前
6分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
Treatment of refractory idiopathic overactive bladder with incobotulinumtoxinA and vibe delivery system (XAVIER): pilot study 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6948533
求助须知:如何正确求助?哪些是违规求助? 8633274
关于积分的说明 18308042
捐赠科研通 6387765
什么是DOI,文献DOI怎么找? 3080908
关于科研通互助平台的介绍 2124270
邀请新用户注册赠送积分活动 2057795